Enliven Therapeutics
ELVNInsider trades and stock quote 2023-2025
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/20/2025 | Sell | Lyssikatos, Joseph P. | CHIEF SCIENTIFIC OFFICER | $21.4 | $267,458 |
| 6/17/2025 | Sell | Kintz, Samuel | PRESIDENT AND CEO | $22.4 | $277,292 |
| 6/13/2025 | Sell | Hohl, Benjamin | CHIEF FINANCIAL OFFICER | $22.6 | $67,655 |
| 6/9/2025 | Sell | Patel, Anish | CHIEF OPERATING OFFICER | $20.7 | $135,574 |
| 6/3/2025 | Sell | Kintz, Samuel | PRESIDENT AND CEO | $20.0 | $150,352 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)